Purified neonatal plasmacytoid dendritic cells overcome intrinsic maturation defect with TLR agonist stimulation

Marielle Gold, Erin Donnelly, Matthew S. Cook, Catherine Leclair, Deborah Lewinsohn

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Neonates are more susceptible than adults to viral and bacterial diseases. We hypothesized that plasmacytoid dendritic cells, the cells that provide large amounts of IFN-α in response to Toll-like receptor 9 (TLR9) agonists, are defective in neonates. To assess the intrinsic functionality of plasmacytoid dendritic cells from neonates we compared IFN-α production by plasmacytoid dendritic cells derived from neonates versus adults in both whole blood and in purified plasmacytoid dendritic cells. TLR9-stimulation of whole blood from adults and neonates resulted in comparable amounts of IFN-α production. However, we observed small but significant differences in IFN-α production from purified CD123+ plasmacytoid dendritic cells from neonates after stimulation with the TLR9 ligand CpG-DNA. Furthermore, we assessed surface expression of co-stimulatory molecules on plasmacytoid dendritic cells after stimulation. While purified CD123+ plasmacytoid dendritic cells from adults up-regulated co-stimulatory molecules CD80 and CD86 with IL-3 alone those from neonates required the addition of CpG-DNA to reach adult levels. Therefore, the intrinsic deficiencies of neonatal plasmacytoid dendritic cells can be mitigated by TLR9 agonists. These results are consistent with the observation that vaccines that effect strong adjuvant activity on dendritic cells can induce protective responses in neonates.

Original languageEnglish (US)
Pages (from-to)34-37
Number of pages4
JournalPediatric Research
Volume60
Issue number1
DOIs
StatePublished - Jul 2006

Fingerprint

Dendritic Cells
Toll-Like Receptor 9
Interleukin-3
DNA
Virus Diseases
Vaccines
Ligands

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Purified neonatal plasmacytoid dendritic cells overcome intrinsic maturation defect with TLR agonist stimulation. / Gold, Marielle; Donnelly, Erin; Cook, Matthew S.; Leclair, Catherine; Lewinsohn, Deborah.

In: Pediatric Research, Vol. 60, No. 1, 07.2006, p. 34-37.

Research output: Contribution to journalArticle

@article{65dd8cae6f4b41eeaccdb82520951c6d,
title = "Purified neonatal plasmacytoid dendritic cells overcome intrinsic maturation defect with TLR agonist stimulation",
abstract = "Neonates are more susceptible than adults to viral and bacterial diseases. We hypothesized that plasmacytoid dendritic cells, the cells that provide large amounts of IFN-α in response to Toll-like receptor 9 (TLR9) agonists, are defective in neonates. To assess the intrinsic functionality of plasmacytoid dendritic cells from neonates we compared IFN-α production by plasmacytoid dendritic cells derived from neonates versus adults in both whole blood and in purified plasmacytoid dendritic cells. TLR9-stimulation of whole blood from adults and neonates resulted in comparable amounts of IFN-α production. However, we observed small but significant differences in IFN-α production from purified CD123+ plasmacytoid dendritic cells from neonates after stimulation with the TLR9 ligand CpG-DNA. Furthermore, we assessed surface expression of co-stimulatory molecules on plasmacytoid dendritic cells after stimulation. While purified CD123+ plasmacytoid dendritic cells from adults up-regulated co-stimulatory molecules CD80 and CD86 with IL-3 alone those from neonates required the addition of CpG-DNA to reach adult levels. Therefore, the intrinsic deficiencies of neonatal plasmacytoid dendritic cells can be mitigated by TLR9 agonists. These results are consistent with the observation that vaccines that effect strong adjuvant activity on dendritic cells can induce protective responses in neonates.",
author = "Marielle Gold and Erin Donnelly and Cook, {Matthew S.} and Catherine Leclair and Deborah Lewinsohn",
year = "2006",
month = "7",
doi = "10.1203/01.pdr.0000220352.13547.f4",
language = "English (US)",
volume = "60",
pages = "34--37",
journal = "Pediatric Research",
issn = "0031-3998",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Purified neonatal plasmacytoid dendritic cells overcome intrinsic maturation defect with TLR agonist stimulation

AU - Gold, Marielle

AU - Donnelly, Erin

AU - Cook, Matthew S.

AU - Leclair, Catherine

AU - Lewinsohn, Deborah

PY - 2006/7

Y1 - 2006/7

N2 - Neonates are more susceptible than adults to viral and bacterial diseases. We hypothesized that plasmacytoid dendritic cells, the cells that provide large amounts of IFN-α in response to Toll-like receptor 9 (TLR9) agonists, are defective in neonates. To assess the intrinsic functionality of plasmacytoid dendritic cells from neonates we compared IFN-α production by plasmacytoid dendritic cells derived from neonates versus adults in both whole blood and in purified plasmacytoid dendritic cells. TLR9-stimulation of whole blood from adults and neonates resulted in comparable amounts of IFN-α production. However, we observed small but significant differences in IFN-α production from purified CD123+ plasmacytoid dendritic cells from neonates after stimulation with the TLR9 ligand CpG-DNA. Furthermore, we assessed surface expression of co-stimulatory molecules on plasmacytoid dendritic cells after stimulation. While purified CD123+ plasmacytoid dendritic cells from adults up-regulated co-stimulatory molecules CD80 and CD86 with IL-3 alone those from neonates required the addition of CpG-DNA to reach adult levels. Therefore, the intrinsic deficiencies of neonatal plasmacytoid dendritic cells can be mitigated by TLR9 agonists. These results are consistent with the observation that vaccines that effect strong adjuvant activity on dendritic cells can induce protective responses in neonates.

AB - Neonates are more susceptible than adults to viral and bacterial diseases. We hypothesized that plasmacytoid dendritic cells, the cells that provide large amounts of IFN-α in response to Toll-like receptor 9 (TLR9) agonists, are defective in neonates. To assess the intrinsic functionality of plasmacytoid dendritic cells from neonates we compared IFN-α production by plasmacytoid dendritic cells derived from neonates versus adults in both whole blood and in purified plasmacytoid dendritic cells. TLR9-stimulation of whole blood from adults and neonates resulted in comparable amounts of IFN-α production. However, we observed small but significant differences in IFN-α production from purified CD123+ plasmacytoid dendritic cells from neonates after stimulation with the TLR9 ligand CpG-DNA. Furthermore, we assessed surface expression of co-stimulatory molecules on plasmacytoid dendritic cells after stimulation. While purified CD123+ plasmacytoid dendritic cells from adults up-regulated co-stimulatory molecules CD80 and CD86 with IL-3 alone those from neonates required the addition of CpG-DNA to reach adult levels. Therefore, the intrinsic deficiencies of neonatal plasmacytoid dendritic cells can be mitigated by TLR9 agonists. These results are consistent with the observation that vaccines that effect strong adjuvant activity on dendritic cells can induce protective responses in neonates.

UR - http://www.scopus.com/inward/record.url?scp=33748061676&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748061676&partnerID=8YFLogxK

U2 - 10.1203/01.pdr.0000220352.13547.f4

DO - 10.1203/01.pdr.0000220352.13547.f4

M3 - Article

C2 - 16690948

AN - SCOPUS:33748061676

VL - 60

SP - 34

EP - 37

JO - Pediatric Research

JF - Pediatric Research

SN - 0031-3998

IS - 1

ER -